Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer’s: treatment perspectives for Alzheimer’s

Código QR

Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer’s: treatment perspectives for Alzheimer’s

Guardado en:

Detalles Bibliográficos
Autores principales:	Natja Haag, Hans Zempel
Formato:	article
Lenguaje:	EN
Publicado:	Nature Publishing Group 2021
Materias:	Medicine R Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/bba88638db8746a6890aa0b5c7f5d91c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Amit Pal, et al.
Publicado: (2021)

Microglia astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
por: VON BERNHARDI,ROMMY, et al.
Publicado: (2001)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Guimei Zhang, et al.
Publicado: (2021)

Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
por: Grzegorz A. Czapski, et al.
Publicado: (2021)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Qinqin Wang, et al.
Publicado: (2021)

N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease
por: Ju Youn Lee, et al.
Publicado: (2020)

Mechanosensing and the Hippo Pathway in Microglia: A Potential Link to Alzheimer’s Disease Pathogenesis?
por: Lucrezia Bruno, et al.
Publicado: (2021)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
por: Joseph Martin Alisky
Publicado: (2008)

Alzheimer’s Disease, Sleep Disordered Breathing, and Microglia: Puzzling out a Common Link
por: Tyler K. Ulland, et al.
Publicado: (2021)

Microglia Mediate the Occurrence and Development of Alzheimer’s Disease Through Ligand-Receptor Axis Communication
por: Chongdong Jian, et al.
Publicado: (2021)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
por: Geraldine Zimmer-Bensch, et al.
Publicado: (2021)

Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease
por: Dragan Gamberger, et al.
Publicado: (2017)

Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer’s disease
por: Nicholas F. Fitz, et al.
Publicado: (2021)

Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
por: Marta Olah, et al.
Publicado: (2020)

Corrigendum: Microglia Mediate the Occurrence and Development of Alzheimer's Disease Through Ligand-Receptor Axis Communication
por: Chongdong Jian, et al.
Publicado: (2021)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
por: Mannu P, et al.
Publicado: (2011)

Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease
por: Jaymie R. Voorhees, et al.
Publicado: (2019)

MODERN IDEAS OF “SLOW SLEEP” AND “REM-SLEEP” AND THEIR ROLE IN PATHOGENESIS OF ALZHEIMER’S DISEASE (REVIEW OF LITERATURE)
por: I. M. Madaeva, et al.
Publicado: (2017)

Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)

Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer’s Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin
por: Xiao Liu, et al.
Publicado: (2021)

Biomarkers in Alzheimer’s disease
por: Janeiro Manuel H., et al.
Publicado: (2020)

Journal of Alzheimer's disease
Publicado: (1998)

Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
por: Tai Kyoung Kim, et al.
Publicado: (2021)

Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross C, et al.
Publicado: (2018)

Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
por: Simona Rossi, et al.
Publicado: (2021)

Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model
por: Guillaume Etter, et al.
Publicado: (2019)

Therapeutic efficacy of repetitive transcranial magnetic stimulation in an animal model of Alzheimer’s disease
por: Jin Seung Choung, et al.
Publicado: (2021)

Controlling Alzheimer’s Disease Through the Deep Brain Stimulation to Thalamic Relay Cells
por: XiaoLi Yang, et al.
Publicado: (2021)

Application of repetitive transcranial magnetic stimulation treatment benefits language performance in Alzheimer’s disease: a case study
por: Georgia Roumpea, et al.
Publicado: (2021)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Hannah Walgrave, et al.
Publicado: (2021)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model
por: Kevin A. Guttenplan, et al.
Publicado: (2020)

The great reset: Transcranial pulse stimulation reduces global EEG-entropy in Alzheimer's Disease
por: Lars Wojtecki, et al.
Publicado: (2021)

Alzheimer's disease: Newer biomarkers
por: Ankit Dangi, et al.
Publicado: (2021)

Disentangling Mitochondria in Alzheimer’s Disease
por: Ashu Johri
Publicado: (2021)

International journal of Alzheimer's disease

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Pathogenesis of Alzheimer′s disease
por: Russell H Swerdlow
Publicado: (2007)

The genetics of Alzheimer's disease
por: Bagyinszky E, et al.
Publicado: (2014)